Xeris Biopharma Holdings, Inc. (XERS)
8.95
+0.29
(+3.35%)
USD |
NASDAQ |
Sep 24, 16:00
8.87
-0.08
(-0.89%)
After-Hours: 19:59
Xeris Biopharma Holdings Gross Profit (Annual) : 238.43M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 238.43M |
| December 31, 2024 | 155.40M |
| December 31, 2023 | 124.43M |
| December 31, 2022 | 76.77M |
| December 31, 2021 | 35.92M |
| Date | Value |
|---|---|
| December 31, 2020 | 11.21M |
| December 31, 2019 | 0.041M |
| December 31, 2018 | 2.103M |
| December 31, 2017 | 1.375M |
| December 31, 2016 | 0.951M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Zevra Therapeutics, Inc. | 85.93M |
| Aclaris Therapeutics, Inc. | 0.542M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |
| Veru, Inc. | -0.1521M |